RNA5S4: A Promising Drug Target and Biomarker (G100169755)

Target Name: RNA5S4

NCBI ID: G100169755

RNA5S4

Other Name(s): RN5S4 | RNA, 5S ribosomal 4

RNA5S4: A Promising Drug Target and Biomarker

RNA5S4 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of gene expression in various organisms, including humans. RNA5S4 plays a critical role in the regulation of cell adhesion, tissue repair, and regeneration. It is also involved in the development and progression of various diseases, including cancer.

The Structure and Function of RNA5S4

RNA5S4 is a small RNA molecule that consists of 54 amino acid residues. It has a highly conserved structure, with a closed circular shape and a single stem-loop region in the middle. The stem-loop region is the region of the molecule where the RNA molecule binds to protein factors, such as transcription factors.

RNA5S4 is expressed in various tissues and cells in the body, including the brain, heart, and gastrointestinal tract. It is also expressed in various types of cancer, including lung, breast, and ovarian cancer. RNA5S4 has been shown to be involved in the regulation of gene expression in various cell types, including cancer cells.

The Potential Druggability of RNA5S4

The potential druggability of RNA5S4 is due to its unique structure and function. One of the key features of RNA5S4 is its role as a negative regulator of gene expression. This means that when RNA5S4 is present in a cell, it can bind to the RNA polymerase and prevent it from binding to the DNA template, thereby inhibiting gene expression.

RNA5S4 is also involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and function. The regulation of cell adhesion is a complex process that involves the interaction of various proteins, including cadherins and integrins. RNA5S4 is shown to be involved in the regulation of cadherin gene expression and cell adhesion.

In addition to its role as a negative regulator of gene expression, RNA5S4 is also a potential biomarker for cancer. The expression of RNA5S4 has been shown to be elevated in various types of cancer, including lung, breast, and ovarian cancer. This suggests that RNA5S4 may be a useful biomarker for the diagnosis and treatment of cancer.

The Future of RNA5S4

The discovery of RNA5S4 has opened up new avenues of research into the regulation of gene expression and the diagnosis and treatment of cancer. One of the key goals of research into RNA5S4 is to understand its role in the regulation of cell adhesion and the development and progression of cancer.

In addition to its potential as a drug target and biomarker, RNA5S4 is also a potential target for small molecules. The highly conserved structure of RNA5S4 makes it a promising target for small molecules that can modulate its function. Further research is needed to determine the full range of potential targets for RNA5S4 and to develop effective strategies for its therapeutic use.

Conclusion

RNA5S4 is a promising drug target and biomarker for the prevention and treatment of cancer. Its unique structure and function as a negative regulator of gene expression and its involvement in the regulation of cell adhesion make it an attractive target for small molecules. Further research is needed to fully understand its potential as a drug and to develop effective strategies for its therapeutic use.

Protein Name: RNA, 5S Ribosomal 4

The "RNA5S4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5S4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets